Research Article
Clinical and Autoimmune Profile of Scleroderma Patients from Western India
Table 1
Clinical presentation of scleroderma patients studied (
).
| | Clinical features | Number () | Percentage positivity |
| | Cutaneous | 108 | 98.2% | | Skin thickening | 80 | 74.1% | | Peripheral vascular | 98 | 89.1% | | Raynaud’s phenomenon | 75 | 76.5% | | Digital ulcers and/or gangrene | 23 | 23.5% | | Pulmonary | 85 | 77.3% | | Interstitial lung disease (ILD) | 75 | 88.2% | | Pulmonary hypertension | 52 | 61.2% | | Renal | 12 | 10.9% | | Musculoskeletal | 43 | 39.1% | | Gastrointestinal | 8 | 7.3% | | Cardiovascular | 15 | 13.6% | | Diffuse cutaneous (dcSSc) | 45 | 40.9% | | Limited cutaneous (lcSSc) | 32 | 29.1% | | Other autoimmune disease overlaps | 33 | 30% | | Rheumatoid arthritis (RA) | 8 | 24.2% | | Mixed connective tissue disease (MCTD) | 5 | 15.2% | | Systemic lupus erythematosus (SLE) | 4 | 12.1% | | Polymyositis/dermatomyositis | 5 | 15.2% | | Others (Sjogren’s syndrome, and hypothyroidism) | 11 | 33.3% |
|
|
